- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
NURECA
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Nureca Limited · Healthcare · Medical Devices
Latest close
342.6 INR
-0.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 27.0% above the Trend Line and sits at 92.4% of its 52-week range. The latest completed week returned -0.3%, after a 46.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high; volume confirmation is below normal.
Setup score
61
out of 100
Latest Close
342.6 INR
7 Aug 2026
1W Return
-0.3%
latest completed week
4W Return
46.9%
short-term follow-through
12W Return
25.5%
quarterly tape
Trend Breadth
44.2%
23 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- Next-week expectancy is negative at 36.73% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.3%
Latest completed week; four-week move 46.9%.
Indicator stack
28/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 36.73%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
25 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 27.0% above the Trend Line and sits at 92.4% of its 52-week range. The latest completed week returned -0.3%, after a 46.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3612-week average 0.21
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.36Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 46.9% over four weeks, 25.5% over 12 weeks, and 44.6% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year23
Trend breadth44.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.29Latest activity-pressure read.
Pressure change435.8%Four-week change in activity pressure.
Leadership28.33Latest relative-leadership reading.
RS change402.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength16/100Blend of value, momentum, and quality. Underlying universe rank 85; rank 1 is best.
Value16/100Relative valuation strength. Underlying universe rank 85; rank 1 is best.
Quality19/100Profitability and accounting quality. Underlying universe rank 82; rank 1 is best.
Momentum80/100Medium-term price momentum. Underlying universe rank 21; rank 1 is best.
Growth96/100Revenue and earnings growth. Underlying universe rank 5; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework2/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 371.5x Price divided by trailing earnings.
- Price / sales
- 2.4x Market value relative to trailing revenue.
- EV / EBITDA
- 58.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -1.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 37.7% Gross profit retained from each unit of revenue.
- Operating margin
- 3.2% Operating profit retained from revenue.
- Free-cash-flow margin
- -2.5% Free cash flow generated from revenue.
- Return on invested capital
- 1.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 34.0% Latest one-year revenue growth.
- EPS growth
- 157.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 4.6% Net share repurchases relative to market value.
- Shareholder yield
- 4.6% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 25 relevant articles.
6 positive · 19 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.2%Distance below the 52-week high.
13-week volatility8.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+20.0%Week of 17 Jul.
Worst week-16.1%Week of 5 Jun.
Latest week-0.3%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains9
Flat weeks0
Modest losses4
Sharp losses7
Recent vol8.7%13-week weekly-return volatility.
Base vol7.9%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew6.7% / -5.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank- / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Devices
4-week rank1 / 3
Group average26.7%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD100.0%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape55/100
Trend, activity pressure, participation, and risk combine to a 55/100 tape read.
Indicator analysis35/100Latest 12-week confirmation: trend 1/12, activity pressure 5/12, relative leadership 6/12.
Activity pressure 0.36; No reversal markers Next-Week ExpectancyNegative 36.73%Next-week expectancy is negative with a 36.73% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors30/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 1; Small Cap Core rank 75 SVQF2/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1539.0 of 1576 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment55/100Weighted news tone is neutral across 25 relevant articles.
Nureca Ltd 10th AGM: Voting Results and Scrutinizer Report for July 28, 2026 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 342.6 INR | -0.3% | 269.8 INR | 291.5 INR | 1.29 | 28.33 | 140.9K | On |
| 31 Jul 2026 | 343.6 INR | 13.9% | 267.8 INR | 291.4 INR | 0.79 | 30.66 | 177.8K | Off |
| 24 Jul 2026 | 301.6 INR | 7.8% | 266.4 INR | 291.4 INR | 0.39 | 18.59 | 771.0K | Off |
| 17 Jul 2026 | 279.8 INR | 20.0% | 265.9 INR | 291.6 INR | -0.02 | 7.96 | 702.6K | Off |
| 10 Jul 2026 | 233.2 INR | 1.8% | 266.0 INR | 292.0 INR | -0.38 | -9.35 | 37.8K | Off |
| 3 Jul 2026 | 229.0 INR | -4.7% | 268.1 INR | 292.7 INR | -0.40 | -11.51 | 45.7K | Off |
| 26 Jun 2026 | 240.3 INR | 1.4% | 270.7 INR | 293.5 INR | -0.51 | -6.60 | 0 | Off |
| 19 Jun 2026 | 237.1 INR | 2.1% | 272.3 INR | 294.3 INR | -0.39 | -7.89 | 5.2K | Off |
| 12 Jun 2026 | 232.1 INR | -1.7% | 272.9 INR | 295.2 INR | -0.27 | -8.46 | 5.1K | Off |
| 5 Jun 2026 | 236.2 INR | -16.1% | 274.3 INR | 296.0 INR | -0.09 | -6.07 | 6.4K | Off |
| 29 May 2026 | 281.5 INR | 3.4% | 275.9 INR | 297.0 INR | 0.27 | 10.80 | 33.1K | Off |
| 22 May 2026 | 272.2 INR | -0.3% | 275.2 INR | 297.9 INR | 0.12 | 6.69 | 27.2K | Off |
| 15 May 2026 | 273.0 INR | -6.9% | 276.3 INR | 298.2 INR | -0.06 | 7.65 | 63.7K | Off |
| 8 May 2026 | 293.1 INR | 10.0% | 276.9 INR | 298.5 INR | -0.26 | 13.34 | 106.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.